Video: Knock on Wood| Webinar: ACR/CHEST ILD Guidelines in Practice
fa-facebookfa-linkedinfa-youtube-playfa-rss

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: hospital

Dr. Guillermo Valenzuela: Truffle Hunter, Tennis Player, Motorcycle Tourist

Carol Patton  |  June 17, 2019

Some would call Guillermo J. Valenzuela, MD, a hunter of sorts. He has accompanied men and their dogs into the forests of Italy in search of white truffles, an underground fungus considered a European delicacy. “Years ago, when visiting my wife’s family in Italy, I walked into a very old restaurant in Parma,” says Dr….

Filed under:ProfilesRheum After 5 Tagged with:Dr. Guillermo Valenzuela

Advanced Practice Providers Should Learn Musculoskeletal Ultrasound

Heather Benham, DNP, RN, CPNP, RhMSUS, on behalf of the ARP Practice Committee   |  June 17, 2019

I have worked as an advanced practice provider (APP) in pediatric rheumatology for nearly 16 years. My collaborating physicians have allowed me to function to the full extent of my scope of practice while allowing me to develop professionally within the subspecialty. My latest endeavor has been learning how to perform musculoskeletal ultrasound (MSUS) and…

Filed under:ConditionsPractice Support Tagged with:Advanced Practice CliniciansMusculoskeletal UltrasoundUltrasound

Genomics Research Highlighted at Lupus Conference

Larry Beresford  |  June 17, 2019

SAN FRANCISCO—The challenges of trying to solve the puzzle of lupus, in light of its broad heterogeneity of symptoms, manifestations in clinical involvement and treatment response, and the sheer complexities of the immune system, are driving researchers into ever more elaborate investigations of how the immune system functions in lupus patients. Genetic, transcriptomic and epigenetic…

Filed under:ConditionsMeeting ReportsSystemic Lupus Erythematosus Tagged with:epigeneticsgenomic researchgenomicsInternational Congress of Lupus

Research Advances Continue in the Fight Against Lupus

Larry Beresford  |  June 17, 2019

SAN FRANCISCO—The 13th International Congress on Systemic Lupus Erythematosus (SLE), held April 5–8, highlighted continuing advances in the fight against lupus, a chronic, inflammatory, autoimmune disease affecting multiple organ systems. The rheumatologist’s ability to control this incurable and life-threatening condition is limited both by its heterogeneous presentation and by the lack of successful treatment options,…

Filed under:ConditionsMeeting ReportsSystemic Lupus Erythematosus Tagged with:International Congress of Lupustargeted immune modulatortargeted therapy

Eosinophilic Gastroenteritis & Eosinophilic Ascites Associated with RA

Helen Lyo, Eugene Han, MD, Shivakumar Vignesh, MD, & Nancy Soloman, MD  |  June 17, 2019

Eosinophilic gastroenteritis (EGE) is a rare condition caused by eosinophilic infiltration of the gastrointestinal (GI) tract. The condition is subdivided into the GI layers it affects: mucosal, muscular and subserosal.1 EGE usually presents with non-specific GI symptoms, such as impaired motility, intestinal obstruction and, rarely, ascites.2 Below, we report a rare case of EGE leading…

Filed under:ConditionsRheumatoid Arthritis Tagged with:Eosinophilic AscitesEosinophilic Gastroenteritis

Thinking Big, Thinking Small

Philip Seo, MD, MHS  |  June 17, 2019

I would like to tell you a story. Two, actually. I am just returning from the 19th International Vasculitis and ANCA Workshop, which is always a fascinating meeting. In its inception, it was a workshop, in the true sense of the word. Now, we discuss anti-neutrophil cytoplasmic antibody (ANCA) testing as casually as we discuss…

Filed under:ConditionsVasculitis Tagged with:ANCA-Associated Vasculitisanti-neutrophil cytoplasmic antibodies (ANCA)genomicsInternational Vasculitis and ANCA WorkshopKawasaki disease

Cincinart / shutterstock.com

Case Report: Sjögren’s Syndrome Plus Neuromyelitis Optica Spectrum Disorder

Swosti Roka Magar, MD, Gita Verma, MD, & Aaroop Haridas, MD   |  June 17, 2019

Sjögren’s syndrome is a chronic multi-system autoimmune disease characterized by inflammation and subsequent destruction of exocrine glands. Sjögren’s syndrome can present with glandular or extra-glandular manifestations. Neuromyelitis optica spectrum disorder (NMOSD) is a rare central nervous system (CNS) autoimmune disease that can present as the initial manifestation in less than 5% of patients with Sjögren’s….

Filed under:ConditionsOther Rheumatic ConditionsSjögren’s Disease Tagged with:immunosuppressive drugsMultiple Sclerosisneuromyelitis optica spectrum disorder (NMOSD)Sjogren's

Biological DMARDs in Elderly RA Patients: Use, Maintenance & Discontinuation

Natasha Yetman  |  June 17, 2019

A study comparing seven biologic DMARDs in RA patients aged 65 years and older found abatacept had the highest retention rate and the lowest discontinuation rate…

Filed under:ConditionsRheumatoid Arthritis Tagged with:abataceptadalimumabbiologic disease-modifying antirheumatic drugsbiologic DMARDsCertolizumab PegoletanerceptGolimumabinfliximabRheumatoid Arthritis (RA)tocilizumab

Beyond Addiction: Medical Therapy for Addiction May Benefit Medical Adherence

Thomas R. Collins  |  June 17, 2019

Treating patients with rheumatic disease for their addictions will also encourage patients to address their overall health conditions, resulting in better medical adherence…

Filed under:Conditions Tagged with:Addictionaddiction treatmentOpioid abuseOpioids

Risk Assessment & Treatment in APS Patients

Thomas R. Collins  |  June 12, 2019

The pathogenesis of antiphospholipid syndrome (APS) is complicated and may involve local inflammation, vasculopathy, pregnancy complications and thrombosis. During the 2019 ACR State-of-the-Art Clinical Symposium, Lisa Sammaritano, MD, addressed the risk assessment and treatment of APS patients…

Filed under:ConditionsOther Rheumatic Conditions Tagged with:2019 State-of-the-Art Clinical SymposiumAntiphospholipid Antibody Syndrome (APS)Hughes Syndromeriskrisk assessmentthrombosis

  • « Previous Page
  • 1
  • …
  • 121
  • 122
  • 123
  • 124
  • 125
  • …
  • 323
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
fa-facebookfa-linkedinfa-youtube-playfa-rss
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences